GRAIL names Joshua Ofman CEO; $800,000 base salary and $2 million RSU award
GRAIL said Dr. Joshua Ofman will serve as its chief executive officer under an amended offer letter effective June 1, 2026. The letter sets his base salary at $800,000, a $2,000,000 restricted stock unit award, and severance terms that differ depending on whether a change in control occurs. The filing also furnished a May 31, 2026 investor presentation on NHS-Galleri and PATHFINDER 2 study data.
Key points
- Base salary set at $800,000; variable compensation target is 100% of base salary from June 1, 2026, versus a prior 60% target that still applies to the part of 2026 before that date
- RSU award with a $2,000,000 grant date value, vesting in equal annual installments on the first four anniversaries of May 31, 2026
- Severance if terminated without cause or resigning for good reason: 24 months of base salary plus 200% of target bonus within the change-in-control period, or 12 months of base salary plus 100% of target bonus otherwise
- Company will reimburse negotiation legal fees up to $25,000
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 01, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.